Skip to main navigation Skip to search Skip to main content

Visible light-cured glycol chitosan hydrogel dressing containing endothelial growth factor and basic fibroblast growth factor accelerates wound healing in vivo

  • Youngbum Yoo
  • , Hoon Hyun
  • , Sun Jung Yoon
  • , So Yeon Kim
  • , Deok Won Lee
  • , Sewook Um
  • , Sung Ok Hong
  • , Dae Hyeok Yang*
  • *Corresponding author for this work

Research output: Contribution to journalJournal articlepeer-review

Abstract

Wounds that heal with excessive scar formation result in poor functional and aesthetic outcomes. To address this, in our study, visible light cured glycol chitosan (GCH) hydrogels containing endothelial growth factor (EGF) and basic fibroblast growth factor (bFGF) were prepared (GCH-EGF, GCH-FGF and GCH-EGF/FGF) and evaluated their efficacies on the improvement of wound healing in vivo. In vitro release test showed that the growth factors were released in a sustained manner along with initial burst for 24 h. In vitro cell proliferation assay of L-929 mouse fibroblast cell line resulted in the superior ability of GCH-EGF/FGF on the rate. In vivo results demonstrated that the growth factor loaded GCHs further enhanced wound healing compared with GCH. In particular, GCH-EGF/EFG showed the most remarkable wound healing effect among the samples.

Original languageEnglish
Pages (from-to)365-372
Number of pages8
JournalJournal of Industrial and Engineering Chemistry
Volume67
DOIs
StatePublished - 2018.11.25

Keywords

  • Basic fibroblast growth factor (bFGF)
  • Endothelial growth factor (EGF)
  • Glycol chitosan (GCH)
  • Visible light curing
  • Wound healing

Quacquarelli Symonds(QS) Subject Topics

  • Engineering - Chemical

Fingerprint

Dive into the research topics of 'Visible light-cured glycol chitosan hydrogel dressing containing endothelial growth factor and basic fibroblast growth factor accelerates wound healing in vivo'. Together they form a unique fingerprint.

Cite this